Concepts (186)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genetic Variation | 18 | 2026 | 1556 | 1.560 |
Why?
|
| Genome, Human | 12 | 2026 | 1322 | 1.200 |
Why?
|
| Neoplasms | 14 | 2023 | 2944 | 1.170 |
Why?
|
| Data Curation | 2 | 2019 | 15 | 1.120 |
Why?
|
| Research Personnel | 1 | 2024 | 141 | 0.780 |
Why?
|
| Genetic Testing | 12 | 2023 | 1100 | 0.690 |
Why?
|
| Databases, Genetic | 11 | 2026 | 507 | 0.670 |
Why?
|
| Genetic Association Studies | 4 | 2025 | 823 | 0.650 |
Why?
|
| Adenomatous Polyposis Coli | 3 | 2024 | 45 | 0.550 |
Why?
|
| Information Dissemination | 1 | 2019 | 195 | 0.520 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2019 | 914 | 0.460 |
Why?
|
| Genomics | 13 | 2026 | 1619 | 0.420 |
Why?
|
| Translocation, Genetic | 1 | 2015 | 348 | 0.380 |
Why?
|
| Gene Frequency | 3 | 2026 | 739 | 0.350 |
Why?
|
| Germ-Line Mutation | 6 | 2023 | 373 | 0.320 |
Why?
|
| Computational Biology | 6 | 2024 | 868 | 0.320 |
Why?
|
| Intellectual Disability | 2 | 2025 | 1080 | 0.260 |
Why?
|
| Germ Cells | 4 | 2023 | 200 | 0.260 |
Why?
|
| Abnormalities, Multiple | 3 | 2025 | 967 | 0.260 |
Why?
|
| Sequence Analysis, DNA | 2 | 2026 | 1723 | 0.230 |
Why?
|
| Precision Medicine | 5 | 2025 | 381 | 0.230 |
Why?
|
| Neoplasms, Connective and Soft Tissue | 1 | 2025 | 3 | 0.230 |
Why?
|
| SMARCB1 Protein | 1 | 2025 | 42 | 0.220 |
Why?
|
| Humans | 39 | 2026 | 130418 | 0.220 |
Why?
|
| Software | 4 | 2026 | 737 | 0.220 |
Why?
|
| Genetics, Medical | 1 | 2026 | 120 | 0.220 |
Why?
|
| Rhabdoid Tumor | 1 | 2025 | 49 | 0.220 |
Why?
|
| Neurilemmoma | 1 | 2025 | 41 | 0.220 |
Why?
|
| Micrognathism | 1 | 2025 | 64 | 0.220 |
Why?
|
| Disease | 1 | 2026 | 124 | 0.220 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2024 | 25 | 0.220 |
Why?
|
| Hand Deformities, Congenital | 1 | 2025 | 95 | 0.210 |
Why?
|
| Social Justice | 1 | 2025 | 65 | 0.210 |
Why?
|
| Neck | 1 | 2025 | 142 | 0.210 |
Why?
|
| Face | 1 | 2025 | 190 | 0.200 |
Why?
|
| DNA Copy Number Variations | 3 | 2019 | 1031 | 0.200 |
Why?
|
| Megalencephaly | 1 | 2023 | 61 | 0.200 |
Why?
|
| Knowledge Bases | 2 | 2020 | 39 | 0.190 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2022 | 3425 | 0.190 |
Why?
|
| Receptor, trkA | 1 | 2022 | 18 | 0.180 |
Why?
|
| Li-Fraumeni Syndrome | 1 | 2022 | 49 | 0.180 |
Why?
|
| Zebrafish | 3 | 2023 | 419 | 0.160 |
Why?
|
| Specialties, Nursing | 1 | 2020 | 4 | 0.160 |
Why?
|
| Education, Nursing, Continuing | 1 | 2020 | 21 | 0.160 |
Why?
|
| Penetrance | 1 | 2020 | 109 | 0.150 |
Why?
|
| Counselors | 1 | 2019 | 23 | 0.150 |
Why?
|
| Medicine | 1 | 2019 | 100 | 0.140 |
Why?
|
| Cadherins | 1 | 2019 | 181 | 0.140 |
Why?
|
| Data Collection | 1 | 2020 | 366 | 0.140 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 279 | 0.140 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2019 | 254 | 0.140 |
Why?
|
| Skin Neoplasms | 1 | 2025 | 899 | 0.130 |
Why?
|
| Antigens, CD | 1 | 2019 | 410 | 0.130 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2023 | 621 | 0.130 |
Why?
|
| Carcinoma, Merkel Cell | 1 | 2016 | 15 | 0.130 |
Why?
|
| Oncogene Proteins, Viral | 1 | 2016 | 61 | 0.120 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2018 | 170 | 0.120 |
Why?
|
| Quality of Health Care | 1 | 2020 | 406 | 0.120 |
Why?
|
| 5'-Nucleotidase | 1 | 2016 | 23 | 0.120 |
Why?
|
| Chromosome Breakage | 1 | 2016 | 156 | 0.120 |
Why?
|
| Wound Healing | 1 | 2020 | 476 | 0.120 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2018 | 490 | 0.120 |
Why?
|
| DCC Receptor | 1 | 2015 | 5 | 0.110 |
Why?
|
| Mutation | 5 | 2025 | 6131 | 0.110 |
Why?
|
| Pharmacogenetics | 1 | 2016 | 203 | 0.110 |
Why?
|
| Chromosome Breakpoints | 1 | 2015 | 82 | 0.110 |
Why?
|
| Base Sequence | 3 | 2015 | 2767 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2015 | 59 | 0.110 |
Why?
|
| Algorithms | 2 | 2024 | 1680 | 0.110 |
Why?
|
| Ovarian Neoplasms | 1 | 2018 | 434 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2015 | 92 | 0.110 |
Why?
|
| INDEL Mutation | 1 | 2015 | 94 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2015 | 108 | 0.110 |
Why?
|
| Molecular Sequence Data | 3 | 2015 | 3507 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2015 | 137 | 0.110 |
Why?
|
| United States | 3 | 2025 | 11827 | 0.100 |
Why?
|
| Genomic Structural Variation | 1 | 2015 | 95 | 0.100 |
Why?
|
| PAX5 Transcription Factor | 1 | 2013 | 16 | 0.100 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2019 | 771 | 0.100 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2016 | 583 | 0.100 |
Why?
|
| Adenoma | 1 | 2015 | 145 | 0.100 |
Why?
|
| Receptors, Cell Surface | 1 | 2015 | 420 | 0.090 |
Why?
|
| Colorectal Neoplasms | 1 | 2018 | 623 | 0.090 |
Why?
|
| Clinical Competence | 1 | 2019 | 1051 | 0.090 |
Why?
|
| Lung Diseases | 1 | 2016 | 395 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2018 | 2847 | 0.090 |
Why?
|
| Cell Cycle Proteins | 1 | 2016 | 714 | 0.090 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2013 | 156 | 0.090 |
Why?
|
| Child | 7 | 2023 | 26165 | 0.080 |
Why?
|
| Phenotype | 3 | 2026 | 4474 | 0.080 |
Why?
|
| Mutation, Missense | 3 | 2023 | 931 | 0.080 |
Why?
|
| Antibodies, Viral | 1 | 2016 | 1167 | 0.080 |
Why?
|
| Alleles | 3 | 2018 | 1685 | 0.070 |
Why?
|
| Age Factors | 1 | 2015 | 2835 | 0.070 |
Why?
|
| Diploidy | 2 | 2020 | 40 | 0.070 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2009 | 274 | 0.070 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2008 | 152 | 0.070 |
Why?
|
| Membrane Proteins | 1 | 2015 | 1602 | 0.060 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 1796 | 0.060 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 2603 | 0.060 |
Why?
|
| Genotype | 2 | 2025 | 2605 | 0.060 |
Why?
|
| Surveys and Questionnaires | 3 | 2020 | 4002 | 0.060 |
Why?
|
| Neurofibromatoses | 1 | 2025 | 9 | 0.060 |
Why?
|
| Guidelines as Topic | 1 | 2026 | 200 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2015 | 1443 | 0.050 |
Why?
|
| Liver Neoplasms | 1 | 2015 | 1393 | 0.050 |
Why?
|
| Growth Disorders | 1 | 2025 | 183 | 0.050 |
Why?
|
| rab5 GTP-Binding Proteins | 1 | 2023 | 14 | 0.050 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2023 | 51 | 0.050 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2023 | 34 | 0.050 |
Why?
|
| Ribonuclease III | 1 | 2023 | 100 | 0.050 |
Why?
|
| Child, Preschool | 2 | 2016 | 14985 | 0.050 |
Why?
|
| Adult | 3 | 2022 | 31127 | 0.050 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2023 | 159 | 0.040 |
Why?
|
| Gene Fusion | 1 | 2022 | 58 | 0.040 |
Why?
|
| Caenorhabditis elegans | 1 | 2023 | 252 | 0.040 |
Why?
|
| Female | 6 | 2020 | 70285 | 0.040 |
Why?
|
| Virulence | 1 | 2022 | 269 | 0.040 |
Why?
|
| Cytoskeletal Proteins | 1 | 2022 | 267 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2008 | 2355 | 0.040 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2022 | 242 | 0.040 |
Why?
|
| Carcinogenesis | 1 | 2022 | 342 | 0.040 |
Why?
|
| Conserved Sequence | 2 | 2009 | 281 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2018 | 27 | 0.030 |
Why?
|
| Developmental Disabilities | 1 | 2023 | 773 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-ret | 1 | 2018 | 39 | 0.030 |
Why?
|
| Male | 4 | 2020 | 64527 | 0.030 |
Why?
|
| Genetic Counseling | 1 | 2019 | 236 | 0.030 |
Why?
|
| Counseling | 1 | 2019 | 237 | 0.030 |
Why?
|
| Loss of Heterozygosity | 1 | 2018 | 124 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2022 | 622 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2020 | 441 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2022 | 726 | 0.030 |
Why?
|
| Access to Information | 1 | 2018 | 46 | 0.030 |
Why?
|
| Models, Theoretical | 1 | 2019 | 363 | 0.030 |
Why?
|
| Genes, p53 | 1 | 2018 | 208 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2016 | 2919 | 0.030 |
Why?
|
| Seroepidemiologic Studies | 1 | 2016 | 165 | 0.030 |
Why?
|
| Chromosome Segregation | 1 | 2016 | 68 | 0.030 |
Why?
|
| Meiosis | 1 | 2016 | 110 | 0.030 |
Why?
|
| Chromosomes | 1 | 2016 | 121 | 0.030 |
Why?
|
| Tumor Virus Infections | 1 | 2016 | 131 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2018 | 748 | 0.030 |
Why?
|
| Disease Management | 1 | 2019 | 559 | 0.030 |
Why?
|
| Mitosis | 1 | 2016 | 194 | 0.030 |
Why?
|
| Family Health | 1 | 2016 | 242 | 0.030 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2018 | 188 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2018 | 769 | 0.030 |
Why?
|
| Recombination, Genetic | 1 | 2016 | 422 | 0.030 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2016 | 210 | 0.030 |
Why?
|
| Homozygote | 1 | 2016 | 539 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2016 | 729 | 0.030 |
Why?
|
| DNA Replication | 1 | 2016 | 358 | 0.030 |
Why?
|
| Population Surveillance | 1 | 2016 | 396 | 0.030 |
Why?
|
| Cell Survival | 1 | 2016 | 837 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2022 | 1606 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2016 | 809 | 0.030 |
Why?
|
| B-Lymphocytes | 1 | 2016 | 509 | 0.020 |
Why?
|
| Syndrome | 1 | 2016 | 1160 | 0.020 |
Why?
|
| DNA Damage | 1 | 2016 | 513 | 0.020 |
Why?
|
| DNA Repair | 1 | 2016 | 575 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2016 | 1056 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2016 | 1300 | 0.020 |
Why?
|
| Pedigree | 1 | 2016 | 1683 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2016 | 857 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 1 | 2018 | 743 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 1827 | 0.020 |
Why?
|
| Animals | 3 | 2023 | 33889 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2016 | 1276 | 0.020 |
Why?
|
| DNA, Intergenic | 1 | 2009 | 18 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2018 | 3682 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2016 | 2476 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2009 | 397 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2016 | 1708 | 0.020 |
Why?
|
| Biomarkers | 1 | 2016 | 3394 | 0.020 |
Why?
|
| Pregnancy | 1 | 2019 | 7380 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2016 | 6423 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 6781 | 0.010 |
Why?
|
| Internet | 1 | 2008 | 418 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2009 | 975 | 0.010 |
Why?
|
| DNA | 1 | 2008 | 1419 | 0.010 |
Why?
|
| Infant | 1 | 2016 | 13269 | 0.010 |
Why?
|
| Time Factors | 1 | 2009 | 6190 | 0.010 |
Why?
|
| Aged | 1 | 2016 | 20894 | 0.010 |
Why?
|
| Brain | 1 | 2009 | 3186 | 0.010 |
Why?
|
| Middle Aged | 1 | 2016 | 28383 | 0.010 |
Why?
|